Matthew Gdovin, an associate professor in the UTSA Department of Biology, has developed a newly patented method to kill cancer cells. His discovery, described in research published in The Journal of Clinical Oncology, may tremendously help people with inoperable or hard-to-reach tumors, as well as young children stricken with cancer.
Gdovin’s top-tier research involves injecting a chemical compound, nitrobenzaldehyde, into the tumor and allowing it to diffuse into the tissue. He then aims a beam of light at the tissue, causing the cells to become very acidic inside and, essentially, commit suicide. Within two hours, Gdovin estimates up to 95 percent of the targeted cancer cells are dead.
“Even though there are many different types of cancers, the one thing they have in common is their susceptibility to this induced cell suicide,” he said.
Gdovin tested his method against triple negative breast cancer, one of the most aggressive types of cancer and one of the hardest to treat. The prognosis for triple negative breast cancer is usually very poor. After one treatment in the laboratory, he was able to stop the tumor from growing and double chances of survival in mice.
“All forms of cancer attempt to make cells acidic on the outside as a way to attract the attention of a blood vessel, which attempts to get rid of the acid,” he said. “Instead, the cancer latches onto the blood vessel and uses it to make the tumor larger and larger.”
Chemotherapy treatments target all cells in the body, and certain chemotherapeutics try to keep cancer cells acidic as a way to kill the cancer. This is what causes many cancer patients to lose their hair and become sickly. Gdovin’s method, however, is more precise and can target just the tumor.
In the past two years, he’s developed his photodynamic cancer therapy to the point where it’s non-invasive. It now requires just an injection of the nitrobenzaldehyde fluid followed by a flash of an ultraviolet light to cause the cancer-killing reaction. Gdovin has now begun to test the method on drug-resistant cancer cells to make his therapy as strong as possible. He’s also started to develop a nanoparticle that can be injected into the body to target metastasized cancer cells. The nanoparticle is activated with a wavelength of light that it can pass harmlessly through skin, flesh and bone and still activate the the cancer-killing nanoparticle.
Gdovin hopes that his non-invasive method will help cancer patients with tumors in areas that have proven problematic for surgeons, such as the brain stem, aorta or spine. It could also help people who have received the maximum amount of radiation treatment and can no longer cope with the scarring and pain that goes along with it, or children who are at risk of developing mutations from radiation as they grow older.
“There are so many types of cancer for which the prognosis is very poor,” he said. “We’re thinking outside the box and finding a way to do what for many people is simply impossible.”
The Latest on: Photodynamic cancer therapy
via Google News
The Latest on: Photodynamic cancer therapy
- AUA 2022: Final Results of a Phase I Trial of WST11 (TOOKAD Soluble) Vascular-Targeted Photodynamic Therapy for Upper Tract Urothelial Carcinomaon May 18, 2022 at 8:19 am
Annual Meeting of the American Urological Association was host to a podium session about upper tract transitional cell carcinoma. Dr. Wesley Yip presented the final results of a Phase 1 trial of WST11 ...
- Photodynamic Therapy Market Size Worth $7.28 billion by 2031: Exclusive Report by Growth Plus Reportson May 18, 2022 at 2:45 am
The Global Photodynamic Therapy Market is expected to clock US$ ~7.28 billion by 2031 owing to the rising incidence of cancer and skin diseases as well as the rising number of R&D activities for ...
- Photodynamic Therapy Market Size Worth $7.28 Billion By 2031: Exclusive Report By Growth Plus Reportson May 16, 2022 at 5:28 am
Factors attributing to the growth of photodynamic therapy market in this region include rising incidence of cancer coupled with growing demand for new biologics in cancer treatment. Moreover ...
- Photodynamic Therapy Market Size Worth $7.28 billion by 2031: Exclusive Report by Growth Plus Reportson May 16, 2022 at 4:12 am
Pune, May 16, 2022 (GLOBE NEWSWIRE) -- The Global Photodynamic Therapy Market is expected to clock US$ ~7.28 billion by 2031 owing to the rising incidence of cancer and skin diseases as well as ...
- Prostate Cancer Perspectiveon May 11, 2022 at 5:00 pm
Medscape Urology, March 17, 2017 Photodynamic Therapy for Prostate Cancer Shows Early Promise Initial study results using photodynamic therapy for shrinking prostate cancer size are promising and ...
- Implantable device delivers personalized photodynamic therapyon May 10, 2022 at 2:05 am
(Courtesy: Justin Baetge/Texas A&M Engineering) Researchers in the US, UK and South Korea have designed a wireless, implantable optoelectronic device that can effectively deliver photodynamic therapy ...
- Wireless Implant for Anti-Cancer Photodynamic Therapyon May 9, 2022 at 11:35 pm
The small device can also be implanted within the body, potentially to provide longer term photodynamic therapy and guard against cancer recurrence. For many cancers, surgery is the primary ...
- Is Focal Therapy the Future for Prostate Cancer?on May 9, 2022 at 5:00 pm
The incidence of low- to intermediate-risk prostate cancer is rising owing to informal ... brachytherapy and photodynamic therapy) with end points derived from biochemical, biopsy and imaging.
- Laser treatmenton May 4, 2022 at 5:01 pm
Doctors can use lasers: instead of blades (scalpels) for surgery to heat and destroy small areas of cancer or precancerous cells together with a light sensitive drug (photodynamic therapy) There are ...
- Photodynamic therapyon April 28, 2022 at 8:02 am
Photodynamic therapy (PDT) is a treatment for several different types of cancer. It uses a light sensitising drug and a very bright light to destroy cancer cells. You can have PDT in different ways.
via Bing News